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A New Type of Accelerator for Charged Particle Cancer 
Therapy 
Rob Edgecock 
STFC Rutherford Appleton Laboratory, Didcot, Oxon, OX11 0QX, UK 
School of Applied Sciences, Huddersfield University, Queensgate, Huddersfield, HD1 3HD, UK 
Abstract. Non-scaling Fixed Field Alternating Gradient accelerators (ns-FFAGs) show great potential for the 
acceleration of protons and light ions for the treatment of certain cancers. They have unique features as they combine 
techniques from the existing types of accelerators, cyclotrons and synchrotrons, and hence look to have advantages over 
both for this application. However, these unique features meant that it was necessary to build one of these accelerators to 
show that it works and to undertake a detailed conceptual design of a medical machine. Both of these have now been 
done. This paper will describe the concepts of this type of accelerator, show results from the proof-of-principle machine 
(EMMA) and described the medical machine (PAMELA).  
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INTRODUCTION 
As is well known, protons are currently accelerated 
for cancer therapy using both cyclotrons and 
synchrotrons, while carbon ions are accelerated using 
just synchrotrons, though super-conducting cyclotrons 
are under development. Both types of accelerator work 
well for this application, though the fact that two are 
used is indicative that neither is ideal. Interest has 
arisen in Fixed Field Alternating Gradient accelerators 
because they combine important features from these 
machines: the fixed magnetic field during acceleration 
from cyclotrons and the alternating gradient or strong 
focusing of synchrotrons. The former allows more 
rapid cycling of the accelerator, limited next by the 
rate at which the RF system frequency can be varied to 
match the revolution frequency of the beam, and easier 
operation than a synchrotron, plus the possibility of 
using super-conducting magnets to make the machine 
more compact. The strong focusing results in a 
relatively compact magnetic ring, giving the 
possibility of extracting the beam at any energy and 
results in the accelerator being able to accelerate both 
protons and carbon ions to full therapy energy. 
 There are two basic types of FFAG [1]. Scaling 
FFAGs were invented in the 1950’s [2,3,4] and a 
number of electron accelerators were constructed at 
the Midwestern Universities Research Association 
(MURA) [1]. They are so-called because they obey a 
“scaling” law, whereby the particle orbits scale with 
energy, resulting in constant betatron tunes during 
acceleration and thereby avoiding resonance crossings 
[5]. Non-scaling FFAGs (ns-FFAGs), on the other 
hand, were invented in the late 1990s [6]. The fact that 
these do not obey the scaling law removes a constraint 
on the design and allows more flexibility. This has 
been exploited in a number of lattice designs. 
The first ns-FFAG invented employed a linear 
lattice for the acceleration of muons in a possible 
future facility called a Neutrino Factory [7]. The 
design has the properties of fast acceleration and large 
acceptance required for the muon acceleration [8]. It 
was also realized early on that this type of accelerator 
looked attractive for other applications, such as 
charged particle therapy, Accelerator Driven Systems 
[9] and the acceleration of high power proton beams 
for other uses. However, their unique features, 
resulting from their non-scaling nature, in particular 
the issue of resonance crossings, meant that a proof-of-
principle machine had to be built to study these 
features and demonstrate that this type of accelerator 
works. This proof-of-principle machine is called 
EMMA. In addition, a conceptual design of a carbon 
and proton therapy complex has been made to show 
that this application is indeed possible for this type of 
accelerator and to determine what the benefits are over 
existing technology. This machine is called PAMELA. 
Both are described in the following sections. 
THE EMMA PROOF-OF-PRINCIPLE 
NS-FFAG 
As a purely experimental machine, the design of 
EMMA [10] is governed by the need to measure how 
this type of accelerator works. It is a 10 to 20 MeV 
electron accelerator, but can accept a beam anywhere 
in that range. It has a linear, doublet lattice, largely for 
cost reasons, and has 42 cells, of 39 cm length, to 
ensure the beam crosses enough cells during an 
standard acceleration cycle, typing 11 turns. There are 
RF cavities in every other cell, except around injection 
and extraction to allow space for kicker magnets. The 
beam is provided by another accelerator called ALICE 
[11] and an injection line has been built between the 
two to transport the beam, match the optics and 
measure the beam parameters before EMMA. The 
beam trajectory around the accelerator is measured by 
82 beam position monitors, two in each cell, except 
around injection and extraction. Diagnostic 
measurements that would damage the beam quality are 
made in a diagnostics beam line, into which the beam 
can be directed at any energy. EMMA construction 
started in April 2007 and was completed in January 
2011. The complete machine is shown in Figure 1. 
The full commissioning of EMMA took place 
between February and April 2011. The results from 
this have been published [12] and these demonstrate 
that the machine works as expected. Here we show 
only two example plots. Figure 2a shows the betatron 
tunes of EMMA during acceleration varying as 
expected, while Figure 2b shows the beam following 
the so-called “serpentine channel” [8] during 
acceleration. The full experimental programme is now 
underway. 
THE PAMELA CHARGED PARTICLE 
THERAPY FFAG 
This is the The aim of the PAMELA project has 
been to design an accelerator that will deliver carbon 
ions at any energy between 110 and 400 MeV/u and 
protons between 60 and 250 MeV, via a gantry with 
the ability to spot scan the beam, and a cycling rate up 
to 1 kHz. This has been achieved and the conceptual 
design is shown in Figure 3. This has separate 
injectors for protons and carbon ions, the former using 
a commercial cyclotron and the latter an RFQ plus 
short linear accelerator. These will deliver 31 MeV 
protons and 8 MeV/u C
6+
 ions to a common injection 
system. The inner, “proton” ring will accelerate 
protons to 250 MeV and carbon ions to 68 MeV/u, 
before both are extracted from this ring and injected 
into the outer, “carbon” ring. The protons can then be 
immediately extracted for therapy, but could also be 
accelerated to higher energies for proton tomography 
[13]. The carbon ring can accelerate carbon ions to 
400 MeV/u before extraction. As well as fixed field 
accelerators, a fixed field transfer line and fixed field 
gantry have been designed. This allows the transport 
and delivery of the beam at any energy and hence 
treatment without changing any magnetic fields other 
than used for spot scanning. This makes it conceivable 
to use super-conducting magnets in the gantry, 
bringing the hope of a significant size reduction 
compared to the existing carbon gantry. 
 
 
FIGURE 1.  The EMMA accelerator photographed from the 
top. The EMMA ring is in the foreground and a section of 
ALICE in the background. The injection line is on the right 
and the diagnostics beam line on the left. 
 
A full conceptual design of PAMELA has been 
undertaken and is soon to be published. Here, only a 
brief description of the main components of the 
machines is given. One of the future measurements 
planned for EMMA is to determine how slow the 
acceleration can be in a linear machine before 
resonance crossings significantly degrade beam 
quality. However, as the acceleration in PAMELA will 
be much slower than EMMA due to the non-
relativistic nature of the ions, it has been assumed that 
a linear lattice cannot be used. Instead, magnets with 
multipoles up to octupole have been employed to 
reduce the betatron tune variations to a tolerable level. 
To increase the available field, these magnets will be 
super-conducting, making use of the fixed field nature 
of these machines [14]. To keep the beam orbit 
excursion small, 18 cm in the proton ring and 22 cm in 
the carbon, 12 cells are used in each, with a triplet 
lattice [15]. To achieve the required cycling rate, it is 
proposed to use ferrite loaded RF cavities, based on 
the existing ISIS 2
nd
 harmonic cavities [16]. A number 
of ferrites have been tested and 500 Hz looks 
achievable. Further work is underway to reach 1 kHz. 
It is planned to use 8 cavities per ring, with a target 
acceleration of 16 kV/cavity/turn. 
 
 
FIGURE 2.  (a) Left: The horizontal and vertical betatron tunes in EMMA as a function of cell number during acceleration from 
around 12 MeV to 18 MeV. 42 cells corresponds to one turn in the machine. (b) Right: The phase of beam with respect to the 
phase of the RF system during acceleration, for 5 different starting phases. The grey lines indicate the so-called serpentine 
acceleration channel. 
 
 
 
FIGURE 3.  The layout of the PAMELA charged particle therapy facility. 
 
The next step in the project is prototyping the main 
machine components, i.e. the ring magnets, RF 
cavities and injection/extraction kicker magnets and 
septum. 
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